Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregor Jordan

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Bioanalysis|August 16, 2025
HPPA as assay substrate for improved capturing of sample variability during cut point analyses in immunogenicity testingGregor Jordan, Alexander Pöhler, Cordula Jany, et al.
Bioanalysis|July 1, 2020
High ionic strength dissociation assay (HISDA) for high drug tolerant immunogenicity testingGregor Jordan, Alexander Pöhler, Florence Guilhot, et al.
The AAPS Journal|February 20, 2026
In Vivo Clearance of Immune Complexes: Insights Into Human Drug/Anti-Drug Antibody Complex Clearance DynamicsEugenia Opolka-Hoffmann, Stephen Fowler, Thomas Bach, et al.
Bioanalysis|October 21, 2015
Quantification of a bifunctional drug in the presence of an immune response: a ligand-binding assay specific for 'active' drugRoland F Staack, Gregor Jordan, Maria Viert, et al.
Bioanalysis|December 5, 2024
A platform immunoassay for the quantification of biotherapeutics with glycine-serine linkersAlexander Pöhler, Michael Antony, Janine Faigle, et al.
Bioanalysis|July 29, 2022
Validation of a method to analyze size distribution of crovalimab-complement C5-eculizumab complexes in human serumMasanobu Nishidate, Norihito Shibahara, Akira Hayasaka, et al.
Bioanalysis|June 16, 2023
High ionic strength dissociation assay reduces dimeric target interference in immunogenicity testingAlexander Pöhler, Cordula Jany, Joachim Butzer, et al.
Analytical Chemistry|December 10, 2016
In Vivo Biotransformation of the Fusion Protein Tetranectin-Apolipoprotein A1 Analyzed by Ligand-Binding Mass Spectrometry Combined with Quantitation by ELISAManfred Zell, Christophe Husser, Roland F Staack, et al.
Mabs|November 12, 2021
The impact of immunogenicity on therapeutic antibody pharmacokinetics: A preclinical evaluation of the effect of immune complex formation and antibody effector function on clearanceEugenia Opolka-Hoffmann, Gregor Jordan, Michael Otteneder, et al.
Bioanalysis|November 4, 2016
Validation of a ligand-binding assay for active protein drug quantification following the 'free analyte QC concept'Eginhard Schick, Roland F Staack, Markus Haak, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Bioanalysis|August 16, 2025
HPPA as assay substrate for improved capturing of sample variability during cut point analyses in immunogenicity testingGregor Jordan, Alexander Pöhler, Cordula Jany, et al.
Bioanalysis|July 1, 2020
High ionic strength dissociation assay (HISDA) for high drug tolerant immunogenicity testingGregor Jordan, Alexander Pöhler, Florence Guilhot, et al.
The AAPS Journal|February 20, 2026
In Vivo Clearance of Immune Complexes: Insights Into Human Drug/Anti-Drug Antibody Complex Clearance DynamicsEugenia Opolka-Hoffmann, Stephen Fowler, Thomas Bach, et al.
Bioanalysis|October 21, 2015
Quantification of a bifunctional drug in the presence of an immune response: a ligand-binding assay specific for 'active' drugRoland F Staack, Gregor Jordan, Maria Viert, et al.
Bioanalysis|December 5, 2024
A platform immunoassay for the quantification of biotherapeutics with glycine-serine linkersAlexander Pöhler, Michael Antony, Janine Faigle, et al.
Bioanalysis|July 29, 2022
Validation of a method to analyze size distribution of crovalimab-complement C5-eculizumab complexes in human serumMasanobu Nishidate, Norihito Shibahara, Akira Hayasaka, et al.
Bioanalysis|June 16, 2023
High ionic strength dissociation assay reduces dimeric target interference in immunogenicity testingAlexander Pöhler, Cordula Jany, Joachim Butzer, et al.
Analytical Chemistry|December 10, 2016
In Vivo Biotransformation of the Fusion Protein Tetranectin-Apolipoprotein A1 Analyzed by Ligand-Binding Mass Spectrometry Combined with Quantitation by ELISAManfred Zell, Christophe Husser, Roland F Staack, et al.
Mabs|November 12, 2021
The impact of immunogenicity on therapeutic antibody pharmacokinetics: A preclinical evaluation of the effect of immune complex formation and antibody effector function on clearanceEugenia Opolka-Hoffmann, Gregor Jordan, Michael Otteneder, et al.
Bioanalysis|November 4, 2016
Validation of a ligand-binding assay for active protein drug quantification following the 'free analyte QC concept'Eginhard Schick, Roland F Staack, Markus Haak, et al.
Pageof 4